Posted inCoronavirus Updates

Monoclonal antibody treatment cuts hospitalisation among high-risk Covid patients: Study

Washington: A combination of two monoclonal antibody treatments keeps high-risk COVID-19 patients out of the hospital when infected with mild to moderate disease, according to an observational study published in The Lancet’s EClinicalMedicine journal. Monoclonal antibodies are laboratory-produced molecules engineered to serve as substitute antibodies that can restore, enhance or mimic the immune system’s attack on […]